Read on Twitter
NOVACYT
VERY interesting development. Pharmacies should have been the domain of rapid tests - so why are they now partnering with labs to do #NCYT PCR tests?
#ALNOV #AVCT #GDR #N4P #ODX #SNG #SKIN https://twitter.com/Stevo04937960/status/1312701144855121920">https://twitter.com/Stevo0493...
VERY interesting development. Pharmacies should have been the domain of rapid tests - so why are they now partnering with labs to do #NCYT PCR tests?
#ALNOV #AVCT #GDR #N4P #ODX #SNG #SKIN https://twitter.com/Stevo04937960/status/1312701144855121920">https://twitter.com/Stevo0493...
The accuracy crackdown has begun & self-reported tests will not be sufficient for anything official. The same with Novacyt& #39;s government contract with up to 750 million last week - pre-ward NPT contracts have been eaten up by NCYT and now pharmacies too.
Novacyt has went from being the King Kong of high throughput 100% centralised testing, to being the de-centralised NHS test King and now the King on the high street too?
The big contracts we& #39;re waiting for haven& #39;t even begun yet - the Saliva rollout, the Care Home rollout...
The big contracts we& #39;re waiting for haven& #39;t even begun yet - the Saliva rollout, the Care Home rollout...
Antibody rollout. And while we& #39;re waiting on those this October, it looks like Novacyt has been eating up the private testing market as well.
It& #39;s utter domination. We are weeks away from declaring contracts estimated to be worth over £1.5 Billion for the 6 months ahead..
It& #39;s utter domination. We are weeks away from declaring contracts estimated to be worth over £1.5 Billion for the 6 months ahead..
They have already got the £1 Billion contracted for, UK Gov £750 mill, and global contracts worth at least £250 million just for the next 6 months ALONE.
Saliva, Care Homes, OEMs etc will be worth at least another £0.5 Bn on top in that same period.
Saliva, Care Homes, OEMs etc will be worth at least another £0.5 Bn on top in that same period.
AND THAT EXCLUDES the new products about to launch, of which we have no idea what contracts will be attached.
VER***** & PRO**** - from PrimerDesign
PathFlow Range - at least 2 from Microgen, one possibly even Antibody LFT
and they& #39;e coming Oct, Nov, Dec.
Savage.
VER***** & PRO**** - from PrimerDesign
PathFlow Range - at least 2 from Microgen, one possibly even Antibody LFT
and they& #39;e coming Oct, Nov, Dec.
Savage.
ON TOP of all that COVID news - they have 2 Acquisitions in Q4 this year, and at least 2 in the first half next year. Those will be BIG revenue generators - as per AGM. One is targeted in the US.
Where does it end?
It doesn& #39;t, as CEO said last week - This is just the BEGINNING
Where does it end?
It doesn& #39;t, as CEO said last week - This is just the BEGINNING
Covid is only worth 22 Billion.
The market Novacyt is pushing into is worth 110 Billion over the next few years, WITHOUT any covid sales factored in.
AND Novacyt has USP now. OPEN Platform Products, World Leading Diagnostics iPhone/Android App for on the go support & training.
The market Novacyt is pushing into is worth 110 Billion over the next few years, WITHOUT any covid sales factored in.
AND Novacyt has USP now. OPEN Platform Products, World Leading Diagnostics iPhone/Android App for on the go support & training.
